Table 7.
Study | Exosomal miRNAs | Molecular pathways | Result |
---|---|---|---|
Liu et al., 2021 (13), | miR-107 | Targeting 14-3-3 η | Downregulation in DLBCL patients: ↓ PFS |
Zare et al., 2020 (22), | miR-155-5P | Targeting INPP5D and SOCS-1 | Upregulation in NK cells: ↓ proliferation and cytotoxicity |
Feng et al., 2019 (20), | 37miRNAs miR-125b-2-3p miR-99a-5p miR-10b-5p miR-125b-5p miR-146b-3p miR-23a-3p miR-1269a let-7c-5p miR-24-3p miR-novel-chr19 26407 |
AMPK signaling* Signaling pathways-regulating pluripotency of stem cells Cellular senescence MicroRNAs in cancer Ras signaling EGFR tyrosine kinase inhibitor resistance mTOR signaling p53 signaling Longevity regulating Autophagy – animal |
Upregulation in DLBCL cell lines |
Feng et al., 2019 (20), | 17 miRNAs miR-122-5p miR-421 miR-144-5p miR-144-3p miR-98-5p miR-577 miR-novel-chr4 51772 miR-novel-chrX 72977 miR-novel-chr20 33917 miR-novel-chrX 73668 |
Signaling pathways- regulating pluripotency- of stem cells* TGF-beta signaling mTOR signaling Oocyte meiosis p53 signaling Proteoglycans in cancer Pathways in cancer MicroRNAs in cancer Transcriptional- misregulation in cancer cGMP-PKG signaling |
Downregulation in DLBCL cell lines |
*In the first pathway, all five miRNAs are involved and, in another pathway, some of them are involved.
miR, microRNA; PFS, Progression-free survival; ↓, Decreased.